Rogelio Hernández-Pando Selected Research

Pulmonary Tuberculosis

2/2022	Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain.
11/2021	Immunotherapeutic effect of adenovirus encoding antimicrobial peptides in experimental pulmonary tuberculosis.
6/2021	The Therapeutic Effect of Intranasal Administration of Dexamethasone in Neuroinflammation Induced by Experimental Pulmonary Tuberculosis.
3/2019	Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis.
1/2019	A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.
1/2019	Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
1/2018	The use of immunotherapy for the treatment of tuberculosis.
12/2017	Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis.
1/2016	Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis.
1/2016	Transcriptional profiles discriminate patients with pulmonary tuberculosis from non-tuberculous individuals depending on the presence of non-insulin diabetes mellitus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rogelio Hernández-Pando Research Topics

Disease

39	Tuberculosis (Tuberculoses) 06/2022 - 01/2005
35	Infections 08/2021 - 08/2002
24	Pulmonary Tuberculosis 02/2022 - 01/2005
11	Inflammation (Inflammations) 01/2022 - 01/2003
11	Neoplasms (Cancer) 08/2021 - 01/2006
8	Pneumonia (Pneumonitis) 11/2021 - 03/2006
8	Proteinuria 05/2018 - 09/2002
6	Fibrosis (Cirrhosis) 08/2021 - 10/2011
6	Acute Kidney Injury (Acute Renal Failure) 11/2020 - 07/2003
6	Granuloma 03/2019 - 06/2004
5	Body Weight (Weight, Body) 01/2021 - 04/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 02/2016 - 08/2011
5	Necrosis 01/2013 - 08/2003
4	Ischemia 01/2022 - 11/2005
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2021 - 09/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 01/2006
4	Chronic Renal Insufficiency 04/2021 - 03/2017
4	Hypoxia (Hypoxemia) 11/2018 - 01/2008
3	Lung Diseases (Lung Disease) 08/2021 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2004
3	Persistent Infection 01/2020 - 09/2012
3	Colitis-Associated Neoplasms 01/2020 - 07/2016
3	Asthma (Bronchial Asthma) 01/2019 - 04/2010
3	Communicable Diseases (Infectious Diseases) 12/2017 - 01/2006
3	Latent Tuberculosis 10/2016 - 01/2010
3	Latent Infection 01/2013 - 05/2007
3	Hypersensitivity (Allergy) 11/2008 - 08/2004
2	Neuroinflammatory Diseases 02/2022 - 06/2021
2	Carcinogenesis 08/2021 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 07/2007
2	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 09/2017 - 03/2017
2	Infarction (Infarctions) 01/2017 - 10/2015
2	Reperfusion Injury 01/2017 - 10/2015
2	Alcoholic Fatty Liver 01/2016 - 04/2015

Drug/Important Bio-Agent (IBA)

27	CytokinesIBA 11/2021 - 09/2002
22	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2003
16	VaccinesIBA 05/2022 - 01/2005
12	AntigensIBA 01/2021 - 08/2004
11	CreatinineIBA 01/2013 - 09/2002
10	CurcuminIBA 02/2022 - 10/2011
10	LipidsIBA 01/2021 - 09/2002
9	Pharmaceutical PreparationsIBA 12/2021 - 12/2006
8	Glutathione PeroxidaseIBA 05/2018 - 08/2003
8	Urea (Carbamide)FDA LinkGeneric 01/2013 - 08/2003
8	NitrogenIBA 01/2013 - 08/2003
7	AntioxidantsIBA 01/2022 - 07/2003
7	Antimicrobial PeptidesIBA 11/2021 - 01/2006
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 01/2004
6	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2006
6	EnzymesIBA 02/2013 - 07/2003
5	Adenosine Triphosphate (ATP)IBA 11/2020 - 10/2011
5	Messenger RNA (mRNA)IBA 10/2016 - 01/2004
5	Acetylglucosaminidase (NAGase)IBA 09/2004 - 08/2003
4	Interleukin-12 (IL 12)IBA 02/2022 - 01/2004
4	Therapeutic UsesIBA 06/2021 - 06/2008
4	CholesterolIBA 01/2021 - 03/2004
4	BCG Vaccine FDA Link 10/2019 - 01/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2004
4	AntibodiesIBA 01/2018 - 02/2004
4	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 09/2004
4	Monoclonal AntibodiesIBA 08/2009 - 08/2002
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2008 - 11/2007
4	Soybean Proteins (Soy Protein)IBA 07/2007 - 09/2002
3	CarbohydratesIBA 01/2022 - 07/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2006
3	titanium dioxide (Titania)FDA Link 12/2020 - 07/2015
3	Potassium Dichromate FDA Link 11/2020 - 09/2015
3	Biological ProductsIBA 01/2019 - 01/2010
3	Hexosaminidases (Hexosaminidase)IBA 05/2018 - 01/2012
3	Liposomes (Liposome)IBA 06/2015 - 02/2004
3	Triglycerides (Triacylglycerol)IBA 04/2015 - 09/2002
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2015 - 12/2006
3	DefensinsIBA 01/2015 - 01/2012
3	Oxidants (Oxidizing Agents)IBA 07/2013 - 08/2011
3	Interferon-gamma (Interferon, gamma)IBA 06/2008 - 01/2006
3	3-nitrotyrosineIBA 11/2007 - 04/2004
3	Gentamicins (Gentamicin)FDA LinkGeneric 04/2004 - 07/2003
3	Caseins (Casein)FDA Link 03/2004 - 09/2002
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2022 - 12/2020
2	CorticosteroneIBA 01/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	LeptinIBA 01/2021 - 01/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020 - 01/2018
2	Macrophage Migration-Inhibitory FactorsIBA 01/2020 - 01/2019
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 07/2006
2	Mitogen-Activated Protein Kinase 3IBA 01/2020 - 01/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 01/2019
2	AcidsIBA 01/2019 - 10/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 02/2013
2	maleic acid (maleate)IBA 05/2018 - 11/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 11/2008
2	sulforaphaneIBA 02/2017 - 08/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 01/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 08/2015

Therapy/Procedure

4	Nephrectomy 04/2021 - 11/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2005
2	Immunotherapy 01/2018 - 01/2006
2	Therapeutics 01/2016 - 09/2013